Is Glaucoma a Two-Pressure-Related Optic Neuropathy? A Systematic Review and Meta-Analysis
PDF
Cite
Share
Request
Review
VOLUME: 54 ISSUE: 2
P: 83 - 89
April 2024

Is Glaucoma a Two-Pressure-Related Optic Neuropathy? A Systematic Review and Meta-Analysis

Turk J Ophthalmol 2024;54(2):83-89
1. Hanoi Medical University, Department of Ophthalmology, Hanoi, Vietnam
2. Hanoi Medical University Hospital, Division of Ophthalmology, Hanoi, Vietnam
3. The University of Sydney School of Medicine, Save Sight Institute, Sydney, Australia
4. Vietnam National Eye Hospital, Department of Glaucoma, Hanoi, Vietnam
5. University of Colorado School of Medicine, Department of Ophthalmology, Aurora, USA
No information available.
No information available
Received Date: 14.10.2023
Accepted Date: 28.01.2024
Publish Date: 19.04.2024
PDF
Cite
Share
Request

ABSTRACT

Objectives:

To review the current literature related to the correlation between translaminar pressure difference (TLPD) and glaucoma.

Materials and Methods:

In this article, we conducted a literature review using MEDLINE via PubMed, Cochrane Eyes and Vision, and Google Scholar from 01/01/2010 to 31/12/2022. Search terms included “glaucoma”, “intraocular pressure”, “translaminar cribrosa pressure gradient/difference”, “intracranial pressure”, and “cerebrospinal fluid pressure”. Of 471 results, 8 articles were selected for the meta-analysis.

Results:

Our meta-analysis demonstrated significantly higher intraocular pressure, lower cerebrospinal fluid pressure (CSFp), and greater TLPD in high-tension and normal-tension glaucoma groups compared to healthy groups.

Conclusion:

The differences in CSFp and TLPD between glaucoma and healthy people detected in current studies suggests a potential relationship between TLPD and glaucoma.

Keywords:
Glaucoma, intraocular pressure, translaminar cribrosa pressure gradient/difference, cerebrospinal fluid pressure, intracranial pressure

Introduction

Glaucoma is a chronic, irreversible optic neuropathy characterized by damage to retinal ganglion cells with or without elevated intraocular pressure (IOP). The current global prevalence of glaucoma is 3.5% in the 40- to 80-year-old population. In 2013, the number of people in this age group suffering from glaucoma was 64.3 million and was predicted to rise to 76 million in 2020 and 112 million in 2040.1

Elevated IOP has long been considered the main and only modifiable risk factor in the pathogenesis of glaucoma. Nonetheless, patients may be diagnosed with normal-tension glaucoma (NTG) or exhibit disease progression even with well-controlled IOP and in the absence of cardiovascular risk factors.2,3 Because IOP exerts its force at the anterior lamina cribrosa and is theoretically countered by the cerebrospinal fluid pressure (CSFp) within the optic nerve sheath which exerts force at the back of the globe, researchers have explored the potential relationship between glaucoma and CSFp.4,5,6,7 CSFp can be calculated by invasive (lumbar puncture) and non-invasive (formula,#*#ref8,#*#9,10,11 transcranial Doppler12) methods. The resulting translaminar pressure difference (TLPD = IOP - CSFp)13 may be normal/balanced or abnormal/imbalanced in either direction. If the intraocular force (IOP) is in excess, glaucoma may result. On the other hand, a TLPD with excessive CSFp and normal IOP has been implicated in the optic disc swelling and posterior globe flattening that may be seen in disorders of elevated intracranial pressure (idiopathic intracranial hypertension) and in astronauts after long-duration spaceflight.14,15 The reverse effect of the TLPD theory can also be seen in ocular hypotony, in which low IOP and normal CSFp can cause optic disc edema.16 Some animal and experimental studies have suggested the possible role of TLPD in glaucoma.17,18,19 We conducted this review because a potential intervention to increase CSFp, reduce IOP, or alter the gradient might have implications in the broader management of glaucoma.

In 2015, Siaudvytyte et al.20 published the first systematic review and meta-analysis about the correlation between CSFp and glaucoma. Their study showed a higher TLPD in subjects with glaucoma compared to healthy controls, as well as a correlation between TLPD and glaucomatous optic neuropathy.20 Most current reviews are qualitative literature searches without any quantitative analysis. Therefore, we conducted this study to systematically evaluate the current evidence that links glaucoma development and progression to alterations in the TLPD.

Materials and Methods

Results

We found 471 results through database searches. After removing duplicated records, we screened 90 studies. Of these screened studies, 25 abstracts met the selection criteria for full-text assessment; 15 of them were excluded with reasons shown in Figure 1, leading to a final inclusion of 8 articles (Table 1).5,9,10,11,22,23,24,25 Quality assessment and extracted data for meta-analysis of the included studies can be found in Supplementary Table 1 and 2.

Glaucoma patients in the HTG group had significant higher IOP (Z=2.65, p=0.008), lower CSFp (Z=5.9, p<0.0001), and higher TLPD (Z=3.9, p<0.0001) than the healthy participants (Figure 2A, B, C). Similarly, the NTG group also had significant higher IOP (Z=93.89, p<0.00001), lower CSFp (Z=2.06, p=0.04), and higher TLPD (Z=2.41, p=0.02) compared to controls (Figure 2D, E, F). Table 2 includes studies supporting the correlation between TLPD and glaucoma progression in terms of structure and function.

Discussion

At the time of the first review in 2015, only 3 prospective studies were available for analysis. Since then, additional prospective studies have been carried out to explore the potential relationship between TLPD and glaucoma risk and progression. Our study found significant differences between glaucoma patients and healthy people in terms of IOP, CSFp, and TLPD in both the HTG and NTG groups. These findings are consistent with the meta-analysis of Siaudvytyte et al.20 as well as most of the included studies, and further contribute to our knowledge of this topic.

In our study, the NTG group had a higher mean IOP than healthy controls (p<0.00001), which was similar to a recent study of Deimantavicius et al.26 This could be because the studies by Ren et al.5 and Lee et al.9 included NTG patients whose IOP was higher on average than in other studies in this systematic review.

Our results also showed that CSFp was significantly lower in both the HTG (p<0.0001) and NTG (p=0.04) groups compared to control groups. According to Wang et al.27, NTG patients had the narrowest orbital optic nerve subarachnoid space (SAS) on magnetic resonance imaging (MRI), suggesting a lower CSFp in comparison to POAG patients and healthy participants. Employing computed tomographic cisternography, Pircher et al.28 indicated that contrast-loaded CSF gradually decreased along the optic nerve of NTG patients while no similar reduction was found in normal subjects. Boye et al.29 measured the flow-range ratio between the intracranial cavity and SAS of the optic nerve in MRI diffusion images and demonstrated that this ratio was significantly lower in NTG compared to healthy people, indicating abnormal CSFp in NTG. In the study by Deimantavicius et al.26, CSFp determined by two-depth transcranial Doppler (TCD) ultrasonography was lower in both the HTG and NTG groups than in healthy participants.

An analysis of 30-year clinical data performed by Knier et al.30 also demonstrated that patients with open-angle glaucoma had significantly lower CSFp compared to the control group.

We did not include the studies of Ren et al.31 (2011) and Xie et al.8 (2018) despite the fact that IOP, CSFp, and TLPD were presented because they did not include any glaucoma patients. Interestingly, Ren et al.31 found that patients with ocular hypertension had higher CSFp than healthy participants. The authors hypothesized that this could be a physiologic compensation to prevent significant imbalance at the level of the lamina cribrosa and subsequent glaucoma progression. This finding was later confirmed by Xie et al.8, who proposed a pre-glaucoma stage in which there were only changes in TLPD with no structural or functional damage. This paved the way for further studies to investigate the TLPD threshold that differentiated normal from the pre-glaucoma stage.

Our findings showed that the TLPD was significantly higher in both the HTG and NTG groups, which was consistent with the findings of Deimantavicius et al.26 The lamina cribrosa is exposed to both IOP and CSFp, so this finding further supports the potential relationship between TLPD and glaucoma mentioned in numerous studies.5,10,11,22,32,33,34,35

Conclusion

Our analysis validated that a significantly lower CSFp and higher TLPD is seen in both HTG and NTG patients in comparison with healthy groups, revealing the potential relationship between glaucoma and TLPD suggested in previous population and prospective studies.

Literature Search

This systematic review and meta-analysis followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline. We searched MEDLINE through PubMed, Cochrane Eyes and Vision, and Google Scholar from 01/01/2010 to 31/12/2022. Keywords included “glaucoma”, “intraocular pressure”, “translaminar cribrosa pressure gradient/difference”, “intracranial pressure”, and “cerebrospinal fluid pressure”. Two independent reviewers (T.T.H. and V-A.B.) independently reviewed all PubMed, Cochrane Eyes and Vision, and Google Scholar abstracts to assess eligibility.

Eligibility Criteria

Peer-reviewed English papers with cross-sectional, case-control, or cohort designs including high-tension glaucoma (HTG) (primary open-angle glaucoma [POAG] or angle-closure glaucoma [PACG]) and NTG participants in the case group and healthy individuals in the control group were selected. Variables such as glaucoma type, IOP, CSFp, and TLPD must have been clearly described. We excluded literature or narrative reviews, animal and computer model studies, and studies not analyzing IOP, CSFp, and TLPD in glaucoma patients. Eligible full-length articles were finally selected by two reviewers (T.T.H. and V-A.B.). The Newcastle-Ottawa Scale, a collaborative project between Newcastle University, Australia and Ottawa, Canada, was applied to assess the quality of non-randomized studies in meta-analysis.21

Outcome Measures

Data extracted for the meta-analysis included IOP, CSFp, TLPD, and CSFp measurements and glaucoma type.

Definitions

Validated CSFp measurements were both invasive (lumbar puncture) and non-invasive (formula,8,9,10,11 transcranial Doppler12). TLPD was defined as IOP - CSFp.3

Statistical Analysis

The data were analyzed using RevMan 5.3 (Cochrane Collaboration). A random effects model was employed to calculate effect size due to the heterogeneity of the studies. A p value less than 0.05 was considered statistically significant.

Study Limitations

There are some limitations related to the measurement of IOP, CSFp, and TLPD. IOP is an indirect estimation, depending on the biomechanical characteristics of cornea, and is assessed with the person in an upright position (Goldmann applanation tonometry, rebound tonometry and pneumotonometry) except for less-frequently used tonometers such as the Schiotz (indentation) or Maclakov (applanation), which can assess IOP in the supine position. CSFp is normally measured by lumbar puncture in the prone or left lateral decubitus position, and because of gravitational effects, CSFp is higher in either of these positions than in the upright position in which IOP is measured. Simplified formulas for TLPD also assume that intraorbital CSFp is similar to intracranial CSFp. However, some previous studies suggested that the orbital SAS does not communicate freely with the intracranial SAS due to trabeculae and septate structures. Therefore, CSFp measured by lumbar puncture might not represent the true CSFp behind the laminar cribrosa.3 Recently, a study by Pircher et al.36 demonstrated an enlarged optic nerve sheath diameter without any increase in lumbar CSFp in NTG patients, suggesting a disrupted connection between intraorbital and intracranial SAS. Our review included studies with different methods of assessing CSFp (lumbar puncture, formula and transcranial Doppler). Hence, a random effects model was used in statistical analysis to account for this heterogeneity. Additionally, TLPD was not an empirical measurement, but instead a calculation based on two variables that were assessed for significance at the same time.

Lindén et al.25 filled this gap in the literature data by measuring CSFp in different positions and found no statistical difference in CSFp between NTG patients and healthy people. However, despite using standardized and specialized equipment for CSFp recording in the study, the study assumed a direct connection between the two SAS compartments.25 Pircher et al.37 was also unable to confirm either a lower lumbar CSFp or higher TLPD in NTG compared to other studies, but their retrospective study did not include a control group. For this reason, this study was not included in our meta-analysis.

Further studies are needed to investigate the communication between the two SAS compartments as well as to evaluate the interaction between IOP and CSFp in different positions, especially in the upright position as suggested by Lindén et al.25 and Pircher et al.37 Two-depth TCD is a non-invasive method with better reliability and stronger relationship with lumbar CSFp than optic nerve sheath diameter and CSFp measured close to the optic nerve, and as such might offer a promising approach to fill the abovementioned gaps.26,38 Discovering the correlation between TLPD and glaucomatous optic neuropathy might enhance the current understanding of NTG pathogenesis and the natural course of glaucoma progression despite well-controlled IOP, leading to future therapeutic interventions in glaucoma.

References

1
Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390:2183-2193.
2
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:829-830.
3
Liu KC, Fleischman D, Lee AG, Killer HE, Chen JJ, Bhatti MT. Current concepts of cerebrospinal fluid dynamics and the translaminar cribrosa pressure gradient: a paradigm of optic disk disease. Surv Ophthalmol. 2020;65:48-66.
4
Berdahl JP, Fautsch MP, Stinnett SS, Allingham RR. Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: a case-control study. Invest Ophthalmol Vis Sci. 2008;49:5412-5418.
5
Ren R, Jonas JB, Tian G, Zhen Y, Ma K, Li S, Wang H, Li B, Zhang X, Wang N. Cerebrospinal fluid pressure in glaucoma: a prospective study. Ophthalmology. 2010;117:259-266.
6
Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology. 2008;115:763-768.
7
Fleischman D, Berdahl JP, Zaydlarova J, Stinnett S, Fautsch MP, Allingham RR. Cerebrospinal fluid pressure decreases with older age. PLoS One. 2012;7:e52664.
8
Xie X, Chen W, Li Z, Thomas R, Li Y, Xian J, Yang D, Wang H, Zhang S, Kang Z, Wang N; Beijing Intraocular and Intracranial Study Group. Noninvasive evaluation of cerebrospinal fluid pressure in ocular hypertension: a preliminary study. Acta Ophthalmol. 2018;96:570-576.
9
Lee SH, Kwak SW, Kang EM, Kim GA, Lee SY, Bae HW, Seong GJ, Kim CY. Estimated Trans-Lamina Cribrosa Pressure Differences in Low-Teen and High-Teen Intraocular Pressure Normal Tension Glaucoma: The Korean National Health and Nutrition Examination Survey. PLoS One. 2016;11:e0148412.
10
Landi L, Casciaro F, Telani S, Traverso CE, Harris A, Verticchio Vercellin AC, Saint L, Iester M. Evaluation of Cerebrospinal Fluid Pressure by a Formula and Its Role in the Pathogenesis of Glaucoma. J Ophthalmol. 2019;2019:1840481.
11
Matuoka ML, Santos KS, Cruz NF, Kasahara N. Correlation between ocular perfusion pressure and translaminar pressure difference in glaucoma: Evidence for a three-pressure disease? Eur J Ophthalmol. 2021;31:2412-2417.
12
Price DA, Grzybowski A, Eikenberry J, Januleviciene I, Verticchio Vercellin AC, Mathew S, Siesky B, Harris A. Review of non-invasive intracranial pressure measurement techniques for ophthalmology applications. Br J Ophthalmol. 2020;104:887-892.
13
Roy Chowdhury U, Fautsch MP. Intracranial Pressure and Its Relationship to Glaucoma: Current Understanding and Future Directions. Med Hypothesis Discov Innov Ophthalmol. 2015;4:71-80.
14
Hamedani AG, Thibault DP, Revere KE, Lee JYK, Grady MS, Willis AW, Liu GT. Trends in the Surgical Treatment of Pseudotumor Cerebri Syndrome in the United States. JAMA Netw Open. 2020;3:e2029669.
15
Mader TH, Gibson CR, Pass AF, Kramer LA, Lee AG, Fogarty J, Tarver WJ, Dervay JP, Hamilton DR, Sargsyan A, Phillips JL, Tran D, Lipsky W, Choi J, Stern C, Kuyumjian R, Polk JD. Optic disc edema, globe flattening, choroidal folds, and hyperopic shifts observed in astronauts after long-duration space flight. Ophthalmology. 2011;118:2058-2069.
16
Albano de Guimarães J, Teixeira GC, Silva TKLD, Moura FC. Optic Disc Edema and Posterior Globe Flattening Secondary to Ocular Hypotony: Case Report and Discussion Regarding Pathophysiology and Clinical Findings. J Neuroophthalmol. 2021;41:220-222.
17
Mathieu E, Gupta N, Paczka-Giorgi LA, Zhou X, Ahari A, Lani R, Hanna J, Yücel YH. Reduced Cerebrospinal Fluid Inflow to the Optic Nerve in Glaucoma. Invest Ophthalmol Vis Sci. 2018;59:5876-5884.
18
Kharmyssov C, Abdildin YG, Kostas KV. Optic nerve head damage relation to intracranial pressure and corneal properties of eye in glaucoma risk assessment. Med Biol Eng Comput. 2019;57:1591-1603.
19
Tong J, Ghate D, Kedar S, Gu L. Relative Contributions of Intracranial Pressure and Intraocular Pressure on Lamina Cribrosa Behavior. J Ophthalmol. 2019;2019:3064949.
20
Siaudvytyte L, Januleviciene I, Daveckaite A, Ragauskas A, Bartusis L, Kucinoviene J, Siesky B, Harris A. Literature review and meta-analysis of translaminar pressure difference in open-angle glaucoma. Eye (Lond). 2015;29:1242-1250.
21
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013; http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
22
Siaudvytyte L, Januleviciene I, Ragauskas A, Bartusis L, Meiliuniene I, Siesky B, Harris A. The difference in translaminar pressure gradient and neuroretinal rim area in glaucoma and healthy subjects. J Ophthalmol. 2014;2014:937360.
23
Jonas JB, Wang N, Nangia V. Ocular Perfusion Pressure vs Estimated Trans-Lamina Cribrosa Pressure Difference in Glaucoma: The Central India Eye and Medical Study (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2015;113:T6.
24
Jonas JB, Wang NL, Wang YX, You QS, Xie XB, Yang DY, Xu L. Estimated trans-lamina cribrosa pressure difference versus intraocular pressure as biomarker for open-angle glaucoma. The Beijing Eye Study 2011. Acta Ophthalmol. 2015;93:7-13.
25
Lindén C, Qvarlander S, Jóhannesson G, Johansson E, Östlund F, Malm J, Eklund A. Normal-Tension Glaucoma Has Normal Intracranial Pressure: A Prospective Study of Intracranial Pressure and Intraocular Pressure in Different Body Positions. Ophthalmology. 2018;125:361-368.
26
Deimantavicius M, Hamarat Y, Lucinskas P, Zakelis R, Bartusis L, Siaudvytyte L, Janulevicienė I, Ragauskas A. Prospective Clinical Study of Non-Invasive Intracranial Pressure Measurements in Open-Angle Glaucoma Patients and Healthy Subjects. Medicina (Kaunas). 2020;56:664.
27
Wang N, Xie X, Yang D, Xian J, Li Y, Ren R, Peng X, Jonas JB, Weinreb RN. Orbital cerebrospinal fluid space in glaucoma: the Beijing intracranial and intraocular pressure (iCOP) study. Ophthalmology. 2012;119:2065-2073.
28
Pircher A, Montali M, Wostyn P, Pircher J, Berberat J, Remonda L, Killer HE. Impaired cerebrospinal fluid dynamics along the entire optic nerve in normal-tension glaucoma. Acta Ophthalmol. 2018;96:562-569.
29
Boye D, Montali M, Miller NR, Pircher A, Gruber P, Killer HE, Remonda L, Berberat J. Flow dynamics of cerebrospinal fluid between the intracranial cavity and the subarachnoid space of the optic nerve measured with a diffusion magnetic resonance imaging sequence in patients with normal tension glaucoma. Clin Exp Ophthalmol. 2018;46:511-518.
30
Knier CG, Fleischman D, Hodge DO, Berdahl JP, Fautsch MP. Three-Decade Evaluation of Cerebrospinal Fluid Pressure in Open-Angle Glaucoma at a Tertiary Care Center. J Ophthalmol. 2020;2020:7487329.
31
Ren R, Zhang X, Wang N, Li B, Tian G, Jonas JB. Cerebrospinal fluid pressure in ocular hypertension. Acta Ophthalmol. 2011;89:142-148.
32
Zhang Q, Jan C, Guo CY, Wang FH, Liang YB, Cao K, Zhang Z, Yang DY, Thomas R, Wang NL; Handan Eye Study Group. Association of intraocular pressure-related factors and retinal vessel diameter with optic disc rim area in subjects with and without primary open angle glaucoma. Clin Exp Ophthalmol. 2018;46:389-399.
33
Ren R, Wang N, Zhang X, Cui T, Jonas JB. Trans-lamina cribrosa pressure difference correlated with neuroretinal rim area in glaucoma. Graefes Arch Clin Exp Ophthalmol. 2011;249:1057-1063.
34
Stoskuviene A, Siaudvytyte L, Januleviciene I, Vaitkus A, Simiene E, Bakstyte V, Ragauskas A, Antman G, Siesky B, Harris A. The Relationship between Intracranial Pressure and Visual Field Zones in Normal-Tension Glaucoma Patients. Diagnostics (Basel). 2023;13:174.
35
Chen BH, Drucker MD, Louis KM, Richards DW. Progression of Normal-Tension Glaucoma After Ventriculoperitoneal Shunt to Decrease Cerebrospinal Fluid Pressure. J Glaucoma. 2016;25:50-52.
36
Pircher A, Montali M, Berberat J, Remonda L, Killer HE. Relationship between the optic nerve sheath diameter and lumbar cerebrospinal fluid pressure in patients with normal tension glaucoma. Eye (Lond). 2017;31:1365-1372.
37
Pircher A, Remonda L, Weinreb RN, Killer HE. Translaminar pressure in Caucasian normal tension glaucoma patients. Acta Ophthalmol. 2017;95:524-531.
38
Siaudvytyte L, Januleviciene I, Ragauskas A, Bartusis L, Siesky B, Harris A. Update in intracranial pressure evaluation methods and translaminar pressure gradient role in glaucoma. Acta Ophthalmol. 2015;93:9-15.